Israel Englander’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Israel Englander’s Portfolio ELOX Stock Details ELOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,647	Closed	-$59K	–	7783
2022 Q1	$59K	Sell	2,647 -1,742	-40%	-$34.3K	﹤0.01%	6348
2021 Q4	$123K	Sell	4,389 -2,468	-36%	-$108K	﹤0.01%	6176
2021 Q3	$447K	Sell	6,857 -2,986	-30%	-$184K	﹤0.01%	5459
2021 Q2	$783K	Buy	+9,843	New	+$821K	﹤0.01%	4902
2020 Q1	–	Sell	-982	Closed	-$289K	–	4721
2019 Q4	$289K	Buy	982 +525	+115%	+$106K	﹤0.01%	3683
2019 Q3	$82K	Sell	457 -83	-15%	-$23.6K	﹤0.01%	3990
2019 Q2	$215K	Buy	+540	New	+$227K	﹤0.01%	3721

Other funds holding ELOX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

AFG

American Financial Group Cincinnati, Ohio $284M AUM 12.01% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Altshuler Shaham Tel Aviv, Israel $8.04B AUM 44.04% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Israel Englander's ELOX Position: Q2 2022 in Review

Israel Englander sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q2 2022, closing a stake of 2,647 shares — an estimated $59K sold.

Israel Englander first reported a position in ELOX in Q2 2019 and held it in 7 quarters. The position peaked at $783K in Q2 2021. 30 funds tracked by Wall St. Rank hold ELOX as of Q2 2022.

Israel Englander reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Israel Englander sold 2,647 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q2 2022, an estimated $59K.
Israel Englander first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q2 2019 and held it in 7 quarters.
Israel Englander's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $783K in Q2 2021.
30 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q2 2022.

Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.